News & media

Here you can find our news and media resources. To comply with applicable regulation in Denmark, press releases and company announcements concerning specific medicinal products or investigational candidates in late-stage development are removed from our website within three weeks of publication. Please contact us to request a copy.

  • Subscribe to news
  • Zealand Pharm Office Part 1 BF3I0670 2
    • COMPANY ANNOUNCEMENT

      Total number of shares and voting rights in Zealand Pharma A/S on September 30, 2024

    • PRESS RELEASE

      Zealand Pharma to participate in the 2024 Cantor Global Healthcare Conference on September 18th

    • COMPANY ANNOUNCEMENT

      Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

    • COMPANY ANNOUNCEMENT

      Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide

    • COMPANY ANNOUNCEMENT

      Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons

    • COMPANY ANNOUNCEMENT

      Total number of shares and voting rights in Zealand Pharma on August 30, 2024

    • COMPANY ANNOUNCEMENT

      Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants

    • COMPANY ANNOUNCEMENT

      Zealand Pharma major shareholder announcement: Bank of America Corporation

    • COMPANY ANNOUNCEMENT

      Zealand Pharma Announces Financial Results for the First Half of 2024

    • PRESS RELEASE

      Zealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial results

    • PRESS RELEASE

      Zealand Pharma Appoints Eric Cox as Chief Commercial Officer

    • COMPANY ANNOUNCEMENT

      Zealand Pharma major shareholder announcement: Van Herk Investments

    Corporate management

    • Adam ALR0640

      Adam Steensberg - President and Chief Executive Officer

    • Zealand Pharma 0285 FIN

      Adam Steensberg - President and Chief Executive Officer

    • Adam ALR0631

      Adam Steensberg - President and Chief Executive Officer

    • Henriette ALR0758

      Henriette Wennicke - Executive Vice President and Chief Financial Officer

    • Christina ALR0693 V2

      Christina Sonnenborg Bredal - Executive Vice President and Chief People Officer

    • David ALR1003

      David Kendall - Executive Vice President, Research & Development and Chief Medical Officer

    • Ivan ALR0873

      Ivan Møller - Executive Vice President and Chief Operating Officer

    • Utpal Singh 1

      Utpal Singh - Executive Vice President and Chief Scientific Officer

    • Utpal Singh 2

      Utpal Singh - Executive Vice President and Chief Scientific Officer

    Research and development

    Logos and icons

    Zealand Pharma 1503

    Stay up-to-date with the latest news from Zealand

    Sign-up to receive press releases and company announcements directly to your inbox

    Subscribe to news

    Investor and Media contacts

    • Anna Krassowksa (1)

      Anna Krassowska

      Vice President, Investor Relations & Corporate Communications

      Email Anna